Page last updated: 2024-10-20

phosphorylcholine and Leishmaniasis, Diffuse Cutaneous

phosphorylcholine has been researched along with Leishmaniasis, Diffuse Cutaneous in 10 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Leishmaniasis, Diffuse Cutaneous: A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.

Research Excerpts

ExcerptRelevanceReference
"Miltefosine was the first oral compound approved for visceral leishmaniasis chemotherapy, and its efficacy against Leishmania donovani has been well documented."1.40In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis. ( Coelho, AC; Costa, CH; Trinconi, CT; Uliana, SR, 2014)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Kassardjian, AA1
Yim, KM1
Rabi, S1
Liang, TZ1
Kim, GH1
Ochoa, MT1
Sattah, MV1
Ahronowitz, IZ1
Godinho, JL1
Georgikopoulou, K1
Calogeropoulou, T1
de Souza, W1
Rodrigues, JC1
Coelho, AC1
Trinconi, CT1
Costa, CH1
Uliana, SR1
Kevric, I1
Cappel, MA1
Keeling, JH1
Bezerra-Souza, A1
Yamamoto, ES1
Laurenti, MD1
Ribeiro, SP1
Passero, LF1
Khandpur, S1
Chaturvedi, P1
Kumar, U1
Khaitan, BK1
Samantaray, JC1
Sharma, VK1
Ordaz-Farias, A1
Muñoz-Garza, FZ1
Sevilla-Gonzalez, FK1
Arana-Guajardo, A1
Ocampo-Candiani, J1
Treviño-Garza, N1
Becker, I1
Camacho-Ortiz, A1
Schraner, C1
Hasse, B1
Hasse, U1
Baumann, D1
Faeh, A1
Burg, G1
Grimm, F1
Mathis, A1
Weber, R1
Günthard, HF1
González, LM1
Vélez, ID1
Zerpa, O1
Ulrich, M1
Blanco, B1
Polegre, M1
Avila, A1
Matos, N1
Mendoza, I1
Pratlong, F1
Ravel, C1
Convit, J1

Reviews

2 reviews available for phosphorylcholine and Leishmaniasis, Diffuse Cutaneous

ArticleYear
Diffuse cutaneous leishmaniasis and HIV co-infection: A case report and review of the literature.
    Journal of cutaneous pathology, 2021, Volume: 48, Issue:6

    Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Darier Disease; Drug Therapy, Combination;

2021
New World and Old World Leishmania Infections: A Practical Review.
    Dermatologic clinics, 2015, Volume: 33, Issue:3

    Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations

2015

Other Studies

8 other studies available for phosphorylcholine and Leishmaniasis, Diffuse Cutaneous

ArticleYear
A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis.
    Experimental parasitology, 2013, Volume: 135, Issue:1

    Topics: Aniline Compounds; Animals; Antiprotozoal Agents; Cell Cycle Checkpoints; Cell Membrane; Cytoskeleto

2013
In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
    PLoS neglected tropical diseases, 2014, Volume: 8, Issue:7

    Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Resistance; Female; Humans; Leishmania;

2014
The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Parasitology international, 2016, Volume: 65, Issue:6 Pt A

    Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Benzylamines; Drug Repositioning; Female; Leishman

2016
Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
    International journal of dermatology, 2010, Volume: 49, Issue:5

    Topics: Adult; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Viscer

2010
Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:1

    Topics: Antiprotozoal Agents; Humans; Leishmania mexicana; Leishmaniasis, Diffuse Cutaneous; Phosphorylcholi

2013
Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-15, Volume: 40, Issue:12

    Topics: Adult; Antiprotozoal Agents; HIV Infections; Humans; Immunocompromised Host; Leishmaniasis, Diffuse

2005
[Miltefosine for disseminated cutaneous leishmaniasis].
    Biomedica : revista del Instituto Nacional de Salud, 2006, Volume: 26 Suppl 1

    Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Diffuse Cutaneous; Male; Phosphorylcholine

2006
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.
    The British journal of dermatology, 2007, Volume: 156, Issue:6

    Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Female; Humans; L

2007